SCHEMBL8320147

SCHEMBL8320147

O=[N+]([O-])c1cccc(Nc2ncnc3cnc(N4CCOCC4)nc23)c1

nearest known ligand 0.58

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SRC P12931 2/20 0.58
BRAF P15056 10/20 0.54
CTSL P07711 1/20 0.54
CTSB P07858 1/20 0.54
CTSS P25774 1/20 0.54
CTSK P43235 1/20 0.54
ABCG2 Q9UNQ0 2/20 0.52
EGFR P00533 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8318906 0.91 ABCG2 (0.54) SRCBRAFABCG2EGFR
SCHEMBL8318621 0.89 ABCG2 (0.52) SRCBRAFABCG2EGFR
SCHEMBL6995080 0.85 BRAF (0.49) BRAF
SCHEMBL8314033 0.83 ABCG2 (0.52) BRAFABCG2
SCHEMBL8317331 0.83 BRAF (0.56) BRAFCTSLCTSBCTSSCTSK
SCHEMBL8319713 0.83 EGFR (0.66) SRCBRAFEGFR
SCHEMBL8320360 0.83 BRAF (0.56) BRAFEGFR
SCHEMBL8315227 0.83 EGFR (0.66) BRAFEGFR
SCHEMBL8316477 0.83 BRAF (0.64) SRCBRAFEGFR
SCHEMBL8316766 0.82 EGFR (0.74) BRAFEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779888-B1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA (DE) 1999-04-28 EP disclosed
EP-0779888-A1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1997-06-25 EP disclosed
WO-1996007657-A1 PYRIMIDO[5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1996-03-14 WO disclosed